Oragenics Inc (OGEN) Quarterly Balance Sheets

Quarterly · GAAP · USD millions
Access OGEN Annual Balance Sheets →
Reviewing balance sheet data across recent quarters allows users to assess how Oragenics Inc manages assets, liabilities, and equity through different cycles.
Quarterly Report, GAAP in USD millions
ITEM
(Jun 30 2026)
(Mar 31 2026) (Dec 31 2025) (Sep 30 2025) (Jun 30 2025)
Assets
Cash & cash equivalent3.86
Short-term Investments, Total0.00
Cash & Short-term Investments3.00
Interest Receivable NO0.00
Other Current Assets0.00
Prepaid Expense And Other Assets Current1.63
Total Current Assets5.49
Other Assets, Noncurrent0.00
Total Assets5.49
Liabilities
Accounts Payable and Accrued Liabilities, Current LI1.82
Notes Payable, Current NO0.00
Total Current Liabilities1.82
Total Long-term Debt0.00
Other liabilities, Noncurrent0.00
Total Liabilities1.82
Stockholders' Equity
Common Stock Value0.00
Additional Paid In Capital Common Stock235.02
Retained Earnings / Accumulated Deficit-231.36
Other Equity0.00
Common Stockholder's Equity3.67
Total Stockholder's Equity3.67
Liabilities & Stockholder's Equity5.49
4 historic quarters locked

Sign in to unlock the full Oragenics Inc balance sheet history.

About Oragenics Inc Quarterly Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC 10-Q filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

  • Form: 10-Q (Period: 20260630)
  • Filed with the SEC: August 13, 2026
  • Source: form10-q.htm

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.
  • Accession: 0001493152-26-037749

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.